奧克蘭大學獲一千六百萬美元醫學研究經費
University of Auckland Receives $16 Million for Medical Research
Updated at: June 15, 2026 at 08:00 AM
紐西蘭奧克蘭大學處於醫學創新的最前沿，持續獲得大額資金以應對全球健康挑戰。
The University of Auckland stands at the forefront of medical innovation, consistently securing major funding to address global health challenges.
雖然在關於該機構的新聞中，1600萬美元這一數字屢見不鮮，但它代表的是多元且具有影響力的投資，而非單一事件。
While the figure of $16 million often appears in news regarding the institution, it represents diverse, high-impact investments rather than a single event.
這筆資金中有一大部分用於支持救命的醫學研究。
A significant portion of this funding supports life-saving medical research.
例如，紐西蘭健康研究委員會在過去15年內向重症監護研究投入了1600萬美元，累計每年為健康系統節省超過5100萬美元。
For instance, the Health Research Council of New Zealand has invested $16 million into intensive care studies over the last 15 years, resulting in annual health system savings of over $51 million.
此外，2020年，該大學獲得了商業、創新與就業部超過1600萬美元的撥款，用以對抗多重耐藥性超級細菌，並評估如纖維沸石等環境風險。
Furthermore, in 2020, the university received more than $16 million from the Ministry of Business, Innovation and Employment to combat multi-drug resistant superbugs and assess environmental risks like erionite fibers.
這些研究補助金與大學的一般營運補貼或私人創業資本截然不同。
These research grants distinguish themselves from general university operating subsidies or private startup capital.
通過像UniServices這類倡議，奧克蘭大學縮小了學術研究與商業應用之間的差距，將投資轉化為公共利益。
By bridging the gap between academic research and commercial application through initiatives like UniServices, the University of Auckland transforms investment into public benefit.
無論是開發新型抗生素還是優化患者護理，該大學始終是創新的重要樞紐，證明了醫學研究是一項能夠為社會健康帶來巨大價值的長期投資。
Whether developing new antibiotics or optimizing patient care, the university remains a vital hub for innovation, proving that medical research is a long-term investment that yields immense value for the health of society.
